Top global arms producers’ revenues surge as major wars rage: SIPRI report

Global arms-industry revenues hit a record $679bn in 2024, up 5.9% year-on-year as the Gaza and Ukraine wars and higher military spending lifted sales across Europe and the US; top US companies drove growth with US-based firms’ combined arms revenues rising to $334bn. Notable movers include SpaceX entering the top 100 with $1.8bn in arms sales, Czech Czechoslovak Group up 193% to $3.6bn, and Israeli firms (Elbit $6.28bn, IAI $5.19bn, Rafael $4.7bn) posting strong gains, while Russia’s two ranked firms grew to $31.2bn despite sanctions; the report flags procurement delays, budget overruns on major programs and supply-chain/critical-minerals risks that could constrain future delivery.

Analysis

Market structure: The SIPRI data (100 firms, $679bn, +5.9% y/y; US top-100 arms revenue +3.8% to $334bn; Europe +13% to $151bn) points to incumbents in munitions, ISR, air-defence and drones as direct winners (e.g., ESLT, Baykar, Hanwha). Losers include Chinese OEMs hit by procurement freezes and any supplier exposed to Chinese export controls on critical minerals. Pricing power is rising for modular systems and munitions (short lead-times → premium pricing), while large platform primes face margin pressure from program delays and overruns.

Risk assessment: Tail risks include sudden ceasefires (demand shock), major sanctions/secondary sanctions regimes (access to markets), and tightened Chinese export controls on rare earths that raise input inflation 10–30% for certain subsystems. Timeline: immediate (days) – volatile knee‑jerk moves on battlefield headlines; short (weeks–months) – contract awards and FY2025 budget votes; long (quarters–years) – ramping of European munitions capacity and supply‑chain reshoring. Hidden dependencies: single-source suppliers for semiconductors/rare earths and export license backlogs that can stall revenue recognition.

Trade implications: Favored trades are tactical overweight in ESLT (Israeli UAV/air‑defence exposure) and selective US primes with stable backlog (LMT, NOC) while underweight/trim GD which has outsized program‑risk exposure to subs and F‑35 supply chains. Cross‑asset: long industrial metals (Cu/Ni) as a 3–6 month play; expect higher term premium in 10y USTs if defence capex accelerates.

Contrarian angles: Consensus underestimates the speed of European munitions capacity build‑out and overestimates China’s ability to immediately substitute controlled critical minerals—creates mispricings in non‑Chinese miners and specialty munitions suppliers. Also political/ESG pressure could periodically re‑rate winners, creating mean‑reversion windows for disciplined entry.

Key Decisions for Investors

• Establish a 2–3% long position in ESLT (Elbit Systems) via 6–12 month 15–20% OTM call spreads (debit), target +25–40% upside if Israeli export sales persist; hard stop if 3‑month trailing revenues decline >15% or major ceasefire announced.
• Add 2% long positions in LMT and NOC each (total 4%) sized as buy-and-hold for 12–18 months; prefer buying stock or 9–12 month covered calls to generate yield—trim if backlog revisions reduce forward revenue guidance by >10%.
• Initiate a pair trade: long LMT (1.5%) / short GD (1.5%) to express relative strength in aerospace/ISR vs program‑overrun exposure; target 12–15% relative return in 6–12 months, stop-loss at 8% adverse move on either leg.
• Rotate 2–3% into miners/ETFs with non-China exposure to critical minerals (copper/nickel/REE-focused names or ETFs) for 3–9 months to hedge input‑price inflation; exit if China announces immediate liberalisation of exports or metal prices fall >20% from local highs.